A detailed history of Strid Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Strid Group, LLC holds 14,665 shares of INCY stock, worth $1.53 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
14,665
Previous 14,665 -0.0%
Holding current value
$1.53 Million
Previous $998,000 24.55%
% of portfolio
0.16%
Previous 0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025

BUY
$55.17 - $71.22 $809,068 - $1.04 Million
14,665 New
14,665 $998,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Strid Group, LLC Portfolio

Follow Strid Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strid Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strid Group, LLC with notifications on news.